all patients had extensive prior treatment and had either cisplatin-refractory disease ( 67 % ) defined as progression within 4 weeks of the last cisplatin dose or failed at least two cisplatin-based regimens ( 35 % ) including a cisplatin-ifosfamide salvage regimen .
C0008838
cisplatin
C0280612
cisplatin-ifosfamide